What can metabolic myopathies teach us about exercise physiology?
Exercise physiologists are interested in metabolic myopathies because they demonstrate how knocking out a component of a specific biochemical pathway can alter cellular metabolism. McArdle's disease (myophosphorylase deficiency) has often been studied in exercise physiology to demonstrate the influence of removing the major anaerobic energy supply to skeletal muscle. Studies of patients with McArdle's disease have shown the increased reliance on blood-borne fuels, the importance of glycogen to maximal aerobic capacity, and the use of nutritional strategies to bypass metabolic defects. Myoadenylate deaminase deficiency is the most common metabolic enzyme deficiency in human skeletal muscle. It is usually compensated for endogenously and does not have a major influence on high-energy power output. Nutritional interventions such as carbohydrate loading and carbohydrate supplementation during exercise are essential components of therapy for patients with fatty acid oxidation defects. Cases of mitochondrial myopathies illustrate the importance of peripheral oxygen extraction for maximal aerobic capacity and show how both exercise and nutritional interventions can partially compensate for these mutations. In summary, metabolic myopathies provide important insights into regulatory and nutritional aspects of the major biochemical pathways of intermediary metabolism in human skeletal muscle.
Tarnopolsky
Mark A
MA
Department of Pediatrics and Medicine, Division of Neurology, McMaster University Medical Centre, Hamilton, ON, Canada. tarnopol@mcmaster.ca
D001378:Azasteroids / Q000378:metabolism; D015444:Exercise / Q000502:physiology*; D005227:Fatty Acids / Q000378:metabolism; D024982:Glycogen Phosphorylase, Muscle Form / Q000502:physiology; D006801:Humans; D008659:Metabolic Diseases / Q000503:physiopathology*; D017240:Mitochondrial Myopathies / Q000503:physiopathology; D009119:Muscle Contraction; D009135:Muscular Diseases / Q000378:metabolism* / Q000503:physiopathology*; D010084:Oxidation-Reduction; D011277:Pregnanediones / Q000378:metabolism
D001378:Azasteroids; D005227:Fatty Acids; D011277:Pregnanediones; C040124:4-aza-4-methylpregnane-3,20-dione; D024982:Glycogen Phosphorylase, Muscle Form